STTK
USDShattuck Labs Inc. Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$1.960
고가
$2.075
저가
$1.858
거래량
0.10M
기업 기본 정보
시가총액
92.5M
산업
생명공학
국가
United States
거래 통계
평균 거래량
0.81M
거래소
NMS
통화
USD
52주 범위
관련 뉴스
Wedbush Initiates Coverage On Shattuck Labs with Outperform Rating, Announces Price Target of $4
Wedbush analyst David Nierengarten initiates coverage on Shattuck Labs with a Outperform rating and announces Price Target of $4.
Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors
— Aggregate net proceeds from private placement expected to fund SL-325 through multiple Phase 2 clinical trials, including in Inflammatory Bowel Disease (IBD) and potentially another autoimmune disease — — Pro forma
Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease
– SL-325 is a potentially first-in-class DR3 antagonist antibody being developed for the treatment of Inflammatory Bowel Disease (IBD) and other inflammatory and immune-mediated diseases – – The Company is on track to
관련 주식
LDTCW
LeddarTech Holdings Inc. Warrants
SAR
Saratoga Investment Corp New
OM
Outset Medical Inc.
BHFAN
Brighthouse Financial Inc. Depositary shares each representing a 1/1000th interest in a share of 5.375% Non-Cumulative Preferred Stock Series C
ASMB
Assembly Biosciences Inc.
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기